Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • seqgirl123
    Member
    • Oct 2008
    • 78

    solexa adapter ligation question

    I am following the Solexa genomic DNA library prep protocol. I ran a gel after I sheared at 250bp, end repaired, 3'A extended, and ligated the genomic DNA to the adapters. I ran a gel on the ligated material in Lane 1. I also ran a gel on the DNA where the same things were done but I eliminated the 3'A extension step in Lane 2. Lane 3 contains DNA ladder.

    Lane 1 material gave a band/smear around 250bp. Lane 2 material showed high molecular weight DNA.

    If I understood how the adapters work from Solexa correctly, the adapters are double stranded and there is a T on one strand (3' end) of the adapter and the other strand (5') is phosphorylated? So, the 3'T on the adapter will ligate to the 3'A on the DNA and the 5' phosphorylated end of the adapter will ligate to the 5'phosphate on the blunt ended DNA?

    And what I'm seeing in the gel in Lane 1 is right because the adapters cannot ligate together due to the incompatibility on their ends. They have Lane 2 shows DNA reannealed to itself and cause the high MW product.

    Does this all sound right?

    If yes and the 5' end of the adapter is phosphorylated, why doesn't this anneal to itself? Or where is the adapter phosphorylated if at all??
  • EPICENTRE
    Registered Vendor
    • Mar 2009
    • 5

    #2
    My understanding is that they use a standard A-tailing. The genomic fragments have 3'-A tails. The adaptors have a 5'-T overhang, not a 3'. This way you should get slightly improved ligation due to the 1-bp annealing in the ligation rxn. The overhangs also will prevent concatemers from forming.

    Comment

    • Nihilo
      Junior Member
      • Oct 2009
      • 2

      #3
      My question might be naive, but the adapters should be able to ligate to either end of the DNA, right ? If this is the case, you would end up with some products with the same primer at each end ...and these products cannot be sequenced since the sequencing primer is specific to only one adapter ... am I missing something ?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:41 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Working...